Frontlight ResearchEarly access
Chronic kidney disease trials in Poland
16 of 20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
- Where
- Chorzów, Gdansk, Lublin, Olsztyn, Oswiecim, Swiecie, Warsaw, Zabrze
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931547 · EU 2026-525471-13-00 - Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Bialystok, Cracow, Gdynia, Jaslo, Katowice, Lodz, Lublin, Piaseczno, Poznan, Pruszkow, Radom, Rzeszow, Swiecie, Szczecin, Tczew, Warsaw, Wroclaw, Zywiec
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Bialystok, Białystok, Bydgoszcz, Cracow, Elblag, Lodz, Lublin, Radom, Ruda Śląska, Skierniewice, Tarnów, Warsaw, Włocławek, Wrocław, Wyszkow
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 3Active, not recruitingA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Bialystok, Gdansk, Lodz, Warsaw
- Age
- 1 year to 18 years
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - Phase 3Not yet taking people in PolandA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Olsztyn, Warsaw, Węgrów, Wroclaw, Żywiec
- Age
- 18 years to 99 years
- People
- 2,800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Brodnica, Katowice, Łęczna, Lodz, Naklo N. Notecią, Pszczyna, Stalowa Wola, Szczecin, Tczew, Warsaw
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - Phase 3Taking peopleEfepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
- Where
- Bialystok, Brodnica, Lodz, Pszczyna, Wadowice, Warsaw, Zyrardow
- Age
- 18 years and over
- People
- 337 worldwide
- Run by
- Genexine Inc.
See details and how to join2023-503634-50-01 - Phase 3Taking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Bedzin, Bialystok, Czeladz, Katowice, Kwidzyn, Lodz, Lublin, Olsztyn, Poznan, Rzeszów, Swiecie, Tczew, Warsaw, Włocławek, Zywiec
- Age
- 18 years and over
- People
- 7,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - Phase 3CompletedA Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
- Where
- Cracow
- Age
- 2 years to 17 years
- People
- 24 worldwide
- Run by
- Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00 - No phaseTaking peopleAssessment of the Impact of Repeated Ischemic Preconditioning Episodes on Hemodynamic and Metabolic Parameters in Patients at Various Stages of Chronic Kidney Disease
- Where
- Lodz
- Age
- 18 years and over
- People
- 60
- Run by
- Medical University of Lodz
See details and how to joinNCT07746102 - Phase 3Taking peopleSACK
- Where
- Bialystok, Cracow, Katowice, Lodz, Olsztyn, Warsaw, Warszawa
- Age
- 18 years and over
- People
- 1,281 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2022-501600-10-00 - Phase 3Taking peopleA Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- Where
- Bialystok, Brodnica, Lodz, Pszczyna, Wadowice, Warsaw, Żyrardów
- Age
- 18 years and over
- People
- 429 worldwide
- Run by
- Genexine, Inc.
See details and how to joinNCT06466785 - Phase 3CompletedA Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- Where
- Bialystok, Cracow, Lodz
- Age
- 2 years to 17 years
- People
- 129 worldwide
- Run by
- AMAG Pharmaceuticals, Inc.
See details and how to joinNCT03619850 · EU 2024-516263-92-00 - Phase 2CompletedA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Bialystok, Katowice, Lodz, Lublin, Oswiecim, Rzeszów, Swiecie, Szczecin, Tczew, Warsaw, Włocławek, Wroclaw, Zabrze
- Age
- 18 years and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00 - No phaseNot yet taking people in PolandPhysical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
- Where
- Warsaw
- Age
- 18 years and over
- People
- 124 worldwide
- Run by
- Biogem s.c.ar.l.
See details and how to joinNCT07160959 - Phase 4Taking peopleCytisine in prolonged dosage versus Nicotine Replacement Therapy in nicotine-dependent patients with Chronic Kidney Disease - single-center, randomized, non-inferiority clinical trial.
- Where
- Warsaw
- Age
- 18 years to 64 years
- People
- 292
- Run by
- Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
See details and how to join2023-509235-39-00